-
1
-
-
80053088189
-
Hepatocellular carcinoma
-
El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365: 1118-1127.
-
(2011)
N Engl J Med
, vol.365
, pp. 1118-1127
-
-
El-Serag, H.B.1
-
2
-
-
20344392430
-
Hepatocellular carcinoma: Epidemiology, risk factors, and screening
-
Sherman M (2005) Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 25: 143-154.
-
(2005)
Semin Liver Dis
, vol.25
, pp. 143-154
-
-
Sherman, M.1
-
3
-
-
39549099942
-
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis
-
DOI 10.1002/hep.22033
-
Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, et al. (2008) Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 47: 511-520. (Pubitemid 351280719)
-
(2008)
Hepatology
, vol.47
, Issue.2
, pp. 511-520
-
-
Schlaeger, C.1
Longerich, T.2
Schiller, C.3
Bewerunge, P.4
Mehrabi, A.5
Toedt, G.6
Kleeff, J.7
Ehemann, V.8
Eils, R.9
Lichter, P.10
Schumacher, P.11
Radlwimmer, B.12
-
4
-
-
0037369657
-
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
-
DOI 10.1053/jhep.2003.50093
-
Velazquez RF, Rodriguez M, Navascues CA, Linares A, Perez R, et al. (2003) Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 37: 520-527. (Pubitemid 36258772)
-
(2003)
Hepatology
, vol.37
, Issue.3
, pp. 520-527
-
-
Velazquez, R.F.1
Rodriguez, M.2
Navascues, C.A.3
Linares, A.4
Perez, R.5
Sotorrios, N.G.6
Martinez, I.7
Rodrigo, L.8
-
5
-
-
34347395244
-
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case-control study of 213 hepatocellular carcinoma patients from India
-
DOI 10.1111/j.1440-1746.2007.04908.x
-
Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, et al. (2007) Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 22: 1104-1111. (Pubitemid 47019860)
-
(2007)
Journal of Gastroenterology and Hepatology
, vol.22
, Issue.7
, pp. 1104-1111
-
-
Kumar, M.1
Kumar, R.2
Hissar, S.S.3
Saraswat, M.K.4
Sharma, B.C.5
Sakhuja, P.6
Sarin, S.K.7
-
6
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, et al. (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378-390.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
-
7
-
-
0141491273
-
Hepatocellular carcinoma
-
DOI 10.1016/S0140-6736(03)14964-1
-
Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362: 1907-1917. (Pubitemid 37518510)
-
(2003)
Lancet
, vol.362
, Issue.9399
, pp. 1907-1917
-
-
Llovet, J.M.1
Burroughs, A.2
Bruix, J.3
-
8
-
-
79955433548
-
Targeted therapies for hepatocellular carcinoma
-
Villanueva A, Llovet JM (2011) Targeted therapies for hepatocellular carcinoma. Gastroenterology 140: 1410-1426.
-
(2011)
Gastroenterology
, vol.140
, pp. 1410-1426
-
-
Villanueva, A.1
Llovet, J.M.2
-
9
-
-
84879579860
-
Emerging Signaling Pathways in Hepatocellular Carcinoma
-
Moeini A, Cornella H, Villanueva A (2012) Emerging Signaling Pathways in Hepatocellular Carcinoma. Liver Cancer 1: 83-93.
-
(2012)
Liver Cancer
, vol.1
, pp. 83-93
-
-
Moeini, A.1
Cornella, H.2
Villanueva, A.3
-
11
-
-
84861183742
-
Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib
-
Lachenmayer A, Toffanin S, Cabellos L, Alsinet C, Hoshida Y, et al. (2012) Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. J Hepatol 56: 1343-1350.
-
(2012)
J Hepatol
, vol.56
, pp. 1343-1350
-
-
Lachenmayer, A.1
Toffanin, S.2
Cabellos, L.3
Alsinet, C.4
Hoshida, Y.5
-
12
-
-
84873097735
-
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
-
Dasari A, Gore L, Messersmith WA, Diab S, Jimeno A, et al. (2013) A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer. Invest New Drugs 31: 115-125.
-
(2013)
Invest New Drugs
, vol.31
, pp. 115-125
-
-
Dasari, A.1
Gore, L.2
Messersmith, W.A.3
Diab, S.4
Jimeno, A.5
-
13
-
-
80052527908
-
The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathway
-
Sarfstein R, Bruchim I, Fishman A, Werner H (2011) The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathway. PLoS One 6: e24468.
-
(2011)
PLoS One
, vol.6
-
-
Sarfstein, R.1
Bruchim, I.2
Fishman, A.3
Werner, H.4
-
14
-
-
33846014703
-
An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function
-
DOI 10.1016/j.molcel.2006.12.008, PII S1097276506008446
-
Scroggins BT, Robzyk K, Wang D, Marcu MG, Tsutsumi S, et al. (2007) An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol Cell 25: 151-159. (Pubitemid 46049066)
-
(2007)
Molecular Cell
, vol.25
, Issue.1
, pp. 151-159
-
-
Scroggins, B.T.1
Robzyk, K.2
Wang, D.3
Marcu, M.G.4
Tsutsumi, S.5
Beebe, K.6
Cotter, R.J.7
Felts, S.8
Toft, D.9
Karnitz, L.10
Rosen, N.11
Neckers, L.12
-
15
-
-
69249209745
-
Vorinostat in solid and hematologic malignancies
-
Siegel D, Hussein M, Belani C, Robert F, Galanis E, et al. (2009) Vorinostat in solid and hematologic malignancies. J Hematol Oncol 2: 31.
-
(2009)
J Hematol Oncol
, vol.2
, pp. 31
-
-
Siegel, D.1
Hussein, M.2
Belani, C.3
Robert, F.4
Galanis, E.5
-
16
-
-
67349201377
-
Targeting tumor angiogenesis with histone deacetylase inhibitors
-
Ellis L, Hammers H, Pili R (2009) Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett 280: 145-153.
-
(2009)
Cancer Lett
, vol.280
, pp. 145-153
-
-
Ellis, L.1
Hammers, H.2
Pili, R.3
-
17
-
-
33751249589
-
Effects of histone deacetylase inhibitors on HIF-1
-
Liang D, Kong X, Sang N (2006) Effects of histone deacetylase inhibitors on HIF-1. Cell Cycle 5: 2430-2435. (Pubitemid 44785816)
-
(2006)
Cell Cycle
, vol.5
, Issue.21
, pp. 2430-2435
-
-
Liang, D.1
Kong, X.2
Sang, N.3
-
18
-
-
0142166332
-
Targeting HIF-1 for cancer therapy
-
Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 721-732
-
-
Semenza, G.L.1
-
19
-
-
2942590732
-
Exploiting tumour hypoxia in cancer treatment
-
Brown JM, Wilson WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4: 437-447. (Pubitemid 38745529)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.6
, pp. 437-447
-
-
Brown, J.M.1
Wilson, W.R.2
-
20
-
-
84859445000
-
Hypoxia-inducible factors: Mediators of cancer progression and targets for cancer therapy
-
Semenza GL (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33: 207-214.
-
(2012)
Trends Pharmacol Sci
, vol.33
, pp. 207-214
-
-
Semenza, G.L.1
-
22
-
-
33747660292
-
Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels: Evidence for an autoregulatory oxygen-sensing system
-
DOI 10.1074/jbc.M601719200
-
Stiehl DP, Wirthner R, Koditz J, Spielmann P, Camenisch G, et al. (2006) Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J Biol Chem 281: 23482-23491. (Pubitemid 44274123)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.33
, pp. 23482-23491
-
-
Stiehl, D.P.1
Wirthner, R.2
Koditz, J.3
Spielmann, P.4
Camenisch, G.5
Wenger, R.H.6
-
23
-
-
33751169387
-
Hypoxia-inducible factor-1 (HIF-1)
-
Ke Q, Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70: 1469-1480.
-
(2006)
Mol Pharmacol
, vol.70
, pp. 1469-1480
-
-
Ke, Q.1
Costa, M.2
-
24
-
-
4444311880
-
Hypoxia inducible factor-1alpha as a cancer drug target
-
Powis G, Kirkpatrick L (2004) Hypoxia inducible factor-1alpha as a cancer drug target. Mol Cancer Ther 3: 647-654. (Pubitemid 39193744)
-
(2004)
Molecular Cancer Therapeutics
, vol.3
, Issue.5
, pp. 647-654
-
-
Powis, G.1
Kirkpatrick, L.2
-
25
-
-
0033954247
-
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia- inducible factor 1alpha
-
Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, et al. (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14: 34-44. (Pubitemid 30051577)
-
(2000)
Genes and Development
, vol.14
, Issue.1
, pp. 34-44
-
-
Ravi, R.1
Mookerjee, B.2
Bhujwalla, Z.M.3
Sutter, C.H.4
Artemov, D.5
Zeng, Q.6
Dillehay, L.E.7
Madan, A.8
Semenza, G.L.9
Bedi, A.10
-
26
-
-
84876266454
-
Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation
-
Hubbi ME, Hu H, Kshitiz, Ahmed I, Levchenko A, et al. (2013) Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation. J Biol Chem 288: 10703-10714.
-
(2013)
J Biol Chem
, vol.288
, pp. 10703-10714
-
-
Hubbi, M.E.1
Hu, H.2
Kshitiz3
Ahmed, I.4
Levchenko, A.5
-
27
-
-
0034663561
-
Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts
-
Thornton RD, Lane P, Borghaei RC, Pease EA, Caro J, et al. (2000) Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem J 350 Pt 1: 307-312.
-
(2000)
Biochem J
, vol.350
, Issue.PART 1
, pp. 307-312
-
-
Thornton, R.D.1
Lane, P.2
Borghaei, R.C.3
Pease, E.A.4
Caro, J.5
-
28
-
-
0037064010
-
Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells
-
DOI 10.1074/jbc.M203781200
-
Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, et al. (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277: 38205-38211. (Pubitemid 35154674)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.41
, pp. 38205-38211
-
-
Fukuda, R.1
Hirota, K.2
Fan, F.3
Jung, Y.D.4
Ellis, L.M.5
Semenza, G.L.6
-
29
-
-
0034050050
-
Loss of PTEN facilitates HIF-1-mediated gene expression
-
Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, et al. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 14: 391-396. (Pubitemid 30131884)
-
(2000)
Genes and Development
, vol.14
, Issue.4
, pp. 391-396
-
-
Zundel, W.1
Schindler, C.2
Haas-Kogan, D.3
Koong, A.4
Kaper, F.5
Chen, E.6
Gottschalk, A.R.7
Ryan, H.E.8
Johnson, R.S.9
Jefferson, A.B.10
Stokoe, D.11
Giaccia, A.J.12
-
30
-
-
84883501150
-
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
-
Semenza GL (2013) HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 123: 3664-3671.
-
(2013)
J Clin Invest
, vol.123
, pp. 3664-3671
-
-
Semenza, G.L.1
-
31
-
-
34547103992
-
Hypoxia and radiotherapy: Opportunities for improved outcomes in cancer treatment
-
DOI 10.1007/s10555-007-9056-0, Special issue on Hypoxia and Cancer, Guest Editor: Gregg L. Semenza
-
Moeller BJ, Richardson RA, Dewhirst MW (2007) Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 26: 241-248. (Pubitemid 47101661)
-
(2007)
Cancer and Metastasis Reviews
, vol.26
, Issue.2
, pp. 241-248
-
-
Moeller, B.J.1
Richardson, R.A.2
Dewhirst, M.W.3
-
32
-
-
79958191830
-
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
-
Rohwer N, Cramer T (2011) Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat 14: 191-201.
-
(2011)
Drug Resist Updat
, vol.14
, pp. 191-201
-
-
Rohwer, N.1
Cramer, T.2
-
33
-
-
33644780111
-
Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha
-
DOI 10.1128/MCB.26.6.2019-2028.2006
-
Kong X, Lin Z, Liang D, Fath D, Sang N, et al. (2006) Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol 26: 2019-2028. (Pubitemid 43346906)
-
(2006)
Molecular and Cellular Biology
, vol.26
, Issue.6
, pp. 2019-2028
-
-
Kong, X.1
Lin, Z.2
Liang, D.3
Fath, D.4
Sang, N.5
Caro, J.6
-
34
-
-
80055077899
-
HDAC4 protein regulates HIF1alpha protein lysine acetylation and cancer cell response to hypoxia
-
Geng H, Harvey CT, Pittsenbarger J, Liu Q, Beer TM, et al. (2011) HDAC4 protein regulates HIF1alpha protein lysine acetylation and cancer cell response to hypoxia. J Biol Chem 286: 38095-38102.
-
(2011)
J Biol Chem
, vol.286
, pp. 38095-38102
-
-
Geng, H.1
Harvey, C.T.2
Pittsenbarger, J.3
Liu, Q.4
Beer, T.M.5
-
35
-
-
84868334619
-
Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)- mediated correction of alpha1-antitrypsin deficiency
-
Bouchecareilh M, Hutt DM, Szajner P, Flotte TR, Balch WE (2012) Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)- mediated correction of alpha1-antitrypsin deficiency. J Biol Chem 287: 38265-38278.
-
(2012)
J Biol Chem
, vol.287
, pp. 38265-38278
-
-
Bouchecareilh, M.1
Hutt, D.M.2
Szajner, P.3
Flotte, T.R.4
Balch, W.E.5
-
36
-
-
77950428804
-
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
-
Hutt DM, Herman D, Rodrigues AP, Noel S, Pilewski JM, et al. (2010) Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol 6: 25-33.
-
(2010)
Nat Chem Biol
, vol.6
, pp. 25-33
-
-
Hutt, D.M.1
Herman, D.2
Rodrigues, A.P.3
Noel, S.4
Pilewski, J.M.5
-
37
-
-
84875163565
-
Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
-
Yan W, Liu S, Xu E, Zhang J, Zhang Y, et al. (2013) Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8. Oncogene 32: 599-609.
-
(2013)
Oncogene
, vol.32
, pp. 599-609
-
-
Yan, W.1
Liu, S.2
Xu, E.3
Zhang, J.4
Zhang, Y.5
-
38
-
-
33749006252
-
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1alpha
-
DOI 10.1158/0008-5472.CAN-05-4598
-
Qian DZ, Kachhap SK, Collis SJ, Verheul HM, Carducci MA, et al. (2006) Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha. Cancer Res 66: 8814-8821. (Pubitemid 44449199)
-
(2006)
Cancer Research
, vol.66
, Issue.17
, pp. 8814-8821
-
-
Qian, D.Z.1
Kachhap, S.K.2
Collis, S.J.3
Verheul, H.M.W.4
Carducci, M.A.5
Atadja, P.6
Pili, R.7
-
39
-
-
28644440158
-
Histone deacetylase inhibitors: Discovery and development as anticancer agents
-
DOI 10.1517/13543784.14.12.1497
-
Marks PA, Dokmanovic M (2005) Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin Investig Drugs 14: 1497-1511. (Pubitemid 41749195)
-
(2005)
Expert Opinion on Investigational Drugs
, vol.14
, Issue.12
, pp. 1497-1511
-
-
Marks, P.A.1
Dokmanovic, M.2
-
40
-
-
3943054839
-
The Sir2 family of protein deacetylases
-
DOI 10.1146/annurev.biochem.73.011303.073651
-
Blander G, Guarente L (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417-435. (Pubitemid 39050375)
-
(2004)
Annual Review of Biochemistry
, vol.73
, pp. 417-435
-
-
Blander, G.1
Guarente, L.2
-
41
-
-
62449178216
-
The critical role of the class III histone deacetylase SIRT1 in cancer
-
Liu T, Liu PY, Marshall GM (2009) The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res 69: 1702-1705.
-
(2009)
Cancer Res
, vol.69
, pp. 1702-1705
-
-
Liu, T.1
Liu, P.Y.2
Marshall, G.M.3
-
42
-
-
78649738532
-
Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) by tirapazamine is dependent on eIF2alpha phosphorylation rather than the mTORC1/4E-BP1 pathway
-
Zhang J, Cao J, Weng Q, Wu R, Yan Y, et al. (2010) Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) by tirapazamine is dependent on eIF2alpha phosphorylation rather than the mTORC1/4E-BP1 pathway. PLoS One 5: e13910.
-
(2010)
PLoS One
, vol.5
-
-
Zhang, J.1
Cao, J.2
Weng, Q.3
Wu, R.4
Yan, Y.5
-
43
-
-
62449203027
-
Control of HIF-1alpha expression by eIF2 alpha phosphorylation-mediated translational repression
-
Zhu K, Chan W, Heymach J, Wilkinson M, McConkey DJ (2009) Control of HIF-1alpha expression by eIF2 alpha phosphorylation-mediated translational repression. Cancer Res 69: 1836-1843.
-
(2009)
Cancer Res
, vol.69
, pp. 1836-1843
-
-
Zhu, K.1
Chan, W.2
Heymach, J.3
Wilkinson, M.4
McConkey, D.J.5
-
44
-
-
84893166893
-
Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells
-
Sesen J, Cammas A, Scotland SJ, Elefterion B, Lemarie A, et al. (2014) Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells. Int J Mol Sci 15: 2172-2190.
-
(2014)
Int J Mol Sci
, vol.15
, pp. 2172-2190
-
-
Sesen, J.1
Cammas, A.2
Scotland, S.J.3
Elefterion, B.4
Lemarie, A.5
-
45
-
-
33747488399
-
PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR
-
DOI 10.1038/nature05029, PII NATURE05029
-
Bernardi R, Guernah I, Jin D, Grisendi S, Alimonti A, et al. (2006) PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature 442: 779-785. (Pubitemid 44258904)
-
(2006)
Nature
, vol.442
, Issue.7104
, pp. 779-785
-
-
Bernardi, R.1
Guernah, I.2
Jin, D.3
Grisendi, S.4
Alimonti, A.5
Teruya-Feldstein, J.6
Cordon-Cardo, C.7
Celeste, S.M.8
Rafii, S.9
Pandolfi, P.P.10
-
46
-
-
30044432434
-
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
-
DOI 10.1038/nm1337
-
Thomas GV, Tran C, Mellinghoff IK, Welsbie DS, Chan E, et al. (2006) Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat Med 12: 122-127. (Pubitemid 43050086)
-
(2006)
Nature Medicine
, vol.12
, Issue.1
, pp. 122-127
-
-
Thomas, G.V.1
Tran, C.2
Mellinghoff, I.K.3
Welsbie, D.S.4
Chan, E.5
Fueger, B.6
Czernin, J.7
Sawyers, C.L.8
-
47
-
-
58049216350
-
Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2
-
Toschi A, Lee E, Gadir N, Ohh M, Foster DA (2008) Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J Biol Chem 283: 34495-34499.
-
(2008)
J Biol Chem
, vol.283
, pp. 34495-34499
-
-
Toschi, A.1
Lee, E.2
Gadir, N.3
Ohh, M.4
Foster, D.A.5
-
48
-
-
62749096589
-
Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms
-
Dunlop EA, Tee AR (2009) Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cell Signal 21: 827-835.
-
(2009)
Cell Signal
, vol.21
, pp. 827-835
-
-
Dunlop, E.A.1
Tee, A.R.2
-
49
-
-
41149153346
-
The mTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency
-
DOI 10.1002/pmic.200700551
-
Magagnin MG, van den Beucken T, Sergeant K, Lambin P, Koritzinsky M, et al. (2008) The mTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency. Proteomics 8: 1019-1028. (Pubitemid 351441441)
-
(2008)
Proteomics
, vol.8
, Issue.5
, pp. 1019-1028
-
-
Magagnin, M.G.1
Van Den, B.T.2
Sergeant, K.3
Lambin, P.4
Koritzinsky, M.5
Devreese, B.6
Wouters, B.G.7
-
50
-
-
84894256995
-
Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase
-
Martineau Y, Wang X, Alain T, Petroulakis E, Shahbazian D, et al. (2014) Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase. Mol Cell Biol 34: 1046-1053.
-
(2014)
Mol Cell Biol
, vol.34
, pp. 1046-1053
-
-
Martineau, Y.1
Wang, X.2
Alain, T.3
Petroulakis, E.4
Shahbazian, D.5
-
51
-
-
33748042296
-
Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer
-
DOI 10.1016/j.critrevonc.2006.03.005, PII S1040842806000655
-
Dong Z, Zhang JT (2006) Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer. Crit Rev Oncol Hematol 59: 169-180. (Pubitemid 44294864)
-
(2006)
Critical Reviews in Oncology/Hematology
, vol.59
, Issue.3
, pp. 169-180
-
-
Dong, Z.1
Zhang, J.-T.2
-
52
-
-
72149095755
-
Eukaryotic stress granules: The ins and outs of translation
-
Buchan JR, Parker R (2009) Eukaryotic stress granules: the ins and outs of translation. Mol Cell 36: 932-941.
-
(2009)
Mol Cell
, vol.36
, pp. 932-941
-
-
Buchan, J.R.1
Parker, R.2
-
53
-
-
79951477620
-
TIAR and TIA-1 mRNA-binding proteins co-aggregate under conditions of rapid oxygen decline and extreme hypoxia and suppress the HIF-1alpha pathway
-
Gottschald OR, Malec V, Krasteva G, Hasan D, Kamlah F, et al. (2010) TIAR and TIA-1 mRNA-binding proteins co-aggregate under conditions of rapid oxygen decline and extreme hypoxia and suppress the HIF-1alpha pathway. J Mol Cell Biol 2: 345-356.
-
(2010)
J Mol Cell Biol
, vol.2
, pp. 345-356
-
-
Gottschald, O.R.1
Malec, V.2
Krasteva, G.3
Hasan, D.4
Kamlah, F.5
-
54
-
-
77957922108
-
The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells
-
Schult C, Dahlhaus M, Ruck S, Sawitzky M, Amoroso F, et al. (2010) The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells. BMC Cancer 10: 560.
-
(2010)
BMC Cancer
, vol.10
, pp. 560
-
-
Schult, C.1
Dahlhaus, M.2
Ruck, S.3
Sawitzky, M.4
Amoroso, F.5
-
55
-
-
34547178178
-
Reconstitution reveals the functional core of mammalian eIF3
-
DOI 10.1038/sj.emboj.7601765, PII 7601765
-
Masutani M, Sonenberg N, Yokoyama S, Imataka H (2007) Reconstitution reveals the functional core of mammalian eIF3. EMBO J 26: 3373-3383. (Pubitemid 47123530)
-
(2007)
EMBO Journal
, vol.26
, Issue.14
, pp. 3373-3383
-
-
Masutani, M.1
Sonenberg, N.2
Yokoyama, S.3
Imataka, H.4
-
56
-
-
55449106579
-
Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation
-
Martineau Y, Derry MC, Wang X, Yanagiya A, Berlanga JJ, et al. (2008) Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol Cell Biol 28: 6658-6667.
-
(2008)
Mol Cell Biol
, vol.28
, pp. 6658-6667
-
-
Martineau, Y.1
Derry, M.C.2
Wang, X.3
Yanagiya, A.4
Berlanga, J.J.5
-
57
-
-
0142213943
-
PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas
-
Okamoto H, Yasui K, Zhao C, Arii S, Inazawa J (2003) PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. Hepatology 38: 1242-1249.
-
(2003)
Hepatology
, vol.38
, pp. 1242-1249
-
-
Okamoto, H.1
Yasui, K.2
Zhao, C.3
Arii, S.4
Inazawa, J.5
-
58
-
-
0033052411
-
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer
-
Nupponen NN, Porkka K, Kakkola L, Tanner M, Persson K, et al. (1999) Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol 154: 1777-1783. (Pubitemid 29262859)
-
(1999)
American Journal of Pathology
, vol.154
, Issue.6
, pp. 1777-1783
-
-
Nupponen, N.N.1
Porkka, K.2
Kakkola, L.3
Tanner, M.4
Persson, K.5
Borg, A.6
Isola, J.7
Visakorpi, T.8
-
59
-
-
21644490138
-
Translational regulation via 59 mRNA leader sequences revealed by mutational analysis of the arabidopsis translation initiation factor subunit eIF3h
-
DOI 10.1105/tpc.104.026880
-
Kim TH, Kim BH, Yahalom A, Chamovitz DA, von Arnim AG (2004) Translational regulation via 59 mRNA leader sequences revealed by mutational analysis of the Arabidopsis translation initiation factor subunit eIF3h. Plant Cell 16: 3341-3356. (Pubitemid 41096010)
-
(2004)
Plant Cell
, vol.16
, Issue.12
, pp. 3341-3356
-
-
Kim, T.-H.1
Kim, B.-H.2
Yahalom, A.3
Chamovitz, D.A.4
Von Arnim, A.G.5
-
60
-
-
84861625981
-
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
-
Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, et al. (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44: 694-698.
-
(2012)
Nat Genet
, vol.44
, pp. 694-698
-
-
Guichard, C.1
Amaddeo, G.2
Imbeaud, S.3
Ladeiro, Y.4
Pelletier, L.5
-
61
-
-
80052668828
-
Peptides derived from the bifunctional kinase/RNase enzyme IRE1alpha modulate IRE1alpha activity and protect cells from endoplasmic reticulum stress
-
Bouchecareilh M, Higa A, Fribourg S, Moenner M, Chevet E (2011) Peptides derived from the bifunctional kinase/RNase enzyme IRE1alpha modulate IRE1alpha activity and protect cells from endoplasmic reticulum stress. FASEB J 25: 3115-3129.
-
(2011)
FASEB J
, vol.25
, pp. 3115-3129
-
-
Bouchecareilh, M.1
Higa, A.2
Fribourg, S.3
Moenner, M.4
Chevet, E.5
-
62
-
-
79952268025
-
TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor
-
Dewey CM, Cenik B, Sephton CF, Dries DR, Mayer P 3rd, et al. (2011) TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol 31: 1098-1108.
-
(2011)
Mol Cell Biol
, vol.31
, pp. 1098-1108
-
-
Dewey, C.M.1
Cenik, B.2
Sephton, C.F.3
Dries, D.R.4
Mayer III, P.5
|